We are live on ! Find out more
NED

Nancy E. Dempze Portfolio holdings

AUM $182M
1-Year Est. Return 16.09%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+16.09%
3 Year Est. Return
+59.1%
5 Year Est. Return
+78.95%
10 Year Est. Return
+300.76%
AUM
$179M
AUM Growth
+$33.5M
Cap. Flow
+$24.2M
Cap. Flow %
13.5%
Top 10 Hldgs %
32.19%
Holding
106
New
25
Increased
35
Reduced
22
Closed
5

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$2.38M
2
WMS icon
Advanced Drainage Systems
WMS
+$1.8M
3
MS icon
Morgan Stanley
MS
+$1.51M
4
WD icon
Walker & Dunlop
WD
+$1.31M
5
GPN icon
Global Payments
GPN
+$1.25M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.38M
2
MDT icon
Medtronic
MDT
+$849K
3
NKE icon
Nike
NKE
+$389K
4
NVS icon
Novartis
NVS
+$376K
5
TMO icon
Thermo Fisher Scientific
TMO
+$263K

Sector Composition

Rank Sector Weight
1 Technology 24.82%
2 Healthcare 18.8%
3 Industrials 12.81%
4 Financials 10.58%
5 Consumer Discretionary 9.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$123B
$2.26M 1.26%
4,869
+2,286
+89% +$1.1M
BALL icon
27
Ball Corp
BALL
$17.5B
$2.18M 1.21%
32,048
+12,899
+67% +$819K
BDX icon
28
Becton Dickinson
BDX
$46.4B
$1.88M 1.05%
7,782
-549
-7% -$129K
WMS icon
29
Advanced Drainage Systems
WMS
$10.6B
$1.81M 1.01%
+11,500
New +$1.8M
MKC icon
30
McCormick & Company Non-Voting
MKC
$14B
$1.69M 0.94%
20,504
+12,179
+146% +$949K
MS icon
31
Morgan Stanley
MS
$319B
$1.56M 0.87%
+15,000
New +$1.51M
GPN icon
32
Global Payments
GPN
$24.1B
$1.54M 0.86%
15,000
+12,000
+400% +$1.25M
BRK.B icon
33
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.45M 0.81%
3,156
WD icon
34
Walker & Dunlop
WD
$1.73B
$1.42M 0.79%
+12,500
New +$1.31M
ABBV icon
35
AbbVie
ABBV
$465B
$1.36M 0.76%
6,892
+5,112
+287% +$954K
CVX icon
36
Chevron
CVX
$382B
$1.34M 0.75%
9,097
-135
-1% -$20.1K
AIG icon
37
American International
AIG
$42.5B
$1.32M 0.74%
18,000
+15,000
+500% +$1.12M
VIG icon
38
Vanguard Dividend Appreciation ETF
VIG
$111B
$1.23M 0.69%
6,231
MRK icon
39
Merck
MRK
$322B
$1.18M 0.66%
10,355
+5,950
+135% +$707K
JPM icon
40
JPMorgan Chase
JPM
$916B
$1.07M 0.6%
5,088
CB icon
41
Chubb
CB
$140B
$1.01M 0.56%
3,500
+1,900
+119% +$521K
REGN icon
42
Regeneron Pharmaceuticals
REGN
$72.9B
$1.01M 0.56%
960
-140
-13% -$156K
SGI
43
Somnigroup International
SGI
$14.4B
$946K 0.53%
+17,322
New +$880K
LYV icon
44
Live Nation Entertainment
LYV
$42.9B
$945K 0.53%
+8,634
New +$835K
WM icon
45
Waste Management
WM
$95B
$860K 0.48%
4,142
-70
-2% -$14.6K
IBM icon
46
IBM
IBM
$213B
$831K 0.46%
3,760
+2,460
+189% +$482K
MORN icon
47
Morningstar
MORN
$7.55B
$796K 0.44%
+2,494
New +$775K
WAB icon
48
Wabtec
WAB
$49.3B
$776K 0.43%
+4,270
New +$701K
GOOG icon
49
Alphabet (Google) Class C
GOOG
$4.11T
$760K 0.42%
4,545
+2,100
+86% +$355K
IWV icon
50
iShares Russell 3000 ETF
IWV
$19.2B
$687K 0.38%
2,102

Similar funds

Nancy E. Dempze's Q3 2024 Portfolio in Review

As of Q3 2024, Nancy E. Dempze held 106 positions worth $179M, up 23% from $146M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Nancy E. Dempze deployed $24.2M of net new capital in Q3 2024, opening 25 new positions and adding to 35 existing holdings. Its largest new stake was Eli Lilly: 2,645 shares worth $2.34M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was NVIDIA, an estimated $1.38M trimmed.

  • Nancy E. Dempze's largest Q3 2024 buy was Eli Lilly: 2,645 shares worth $2.34M.
  • Nancy E. Dempze added most to Global Payments in Q3 2024, an estimated $1.25M increase.
  • Nancy E. Dempze's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $1.38M.
  • Nancy E. Dempze fully exited Nike in Q3 2024, selling an estimated $389K.
  • Nancy E. Dempze's ten largest holdings make up 32% of its $179M portfolio in Q3 2024.
  • Nancy E. Dempze opened 25 new positions and closed 5 in Q3 2024.
  • Nancy E. Dempze's portfolio value rose 23% quarter-over-quarter to $179M.

Based on Nancy E. Dempze's 13F filing for Q3 2024, filed 12 Nov 2024.